These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7105 related articles for article (PubMed ID: 2365496)

  • 1. Secreted phosphoprotein mRNA is induced during multi-stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblasts.
    Craig AM; Bowden GT; Chambers AF; Spearman MA; Greenberg AH; Wright JA; McLeod M; Denhardt DT
    Int J Cancer; 1990 Jul; 46(1):133-7. PubMed ID: 2365496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin, a transformation-associated cell adhesion phosphoprotein, is induced by 12-O-tetradecanoylphorbol 13-acetate in mouse epidermis.
    Craig AM; Smith JH; Denhardt DT
    J Biol Chem; 1989 Jun; 264(16):9682-9. PubMed ID: 2722855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the major phosphoprotein secreted by many rodent cell lines as 2ar/osteopontin: enhanced expression in H-ras-transformed 3T3 cells.
    Craig AM; Nemir M; Mukherjee BB; Chambers AF; Denhardt DT
    Biochem Biophys Res Commun; 1988 Nov; 157(1):166-73. PubMed ID: 3058125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
    La E; Muga SJ; Locniskar MF; Fischer SM
    Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells.
    Chambers AF; Behrend EI; Wilson SM; Denhardt DT
    Anticancer Res; 1992; 12(1):43-7. PubMed ID: 1567180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of the 55 and 44 kDa forms of secreted phosphoprotein 1 (SPP-1, osteopontin) in normal and transformed rat bone cells by osteotropic hormones, growth factors and a tumor promoter.
    Kasugai S; Zhang Q; Overall CM; Wrana JL; Butler WT; Sodek J
    Bone Miner; 1991 Jun; 13(3):235-50. PubMed ID: 1863811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1 alpha,25-dihydroxyvitamin D3 stimulates synthesis and secretion of nonphosphorylated osteopontin (secreted phosphoprotein 1) in mouse JB6 epidermal cells.
    Chang PL; Prince CW
    Cancer Res; 1991 Apr; 51(8):2144-50. PubMed ID: 2009532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The murine gene encoding secreted phosphoprotein 1 (osteopontin): promoter structure, activity, and induction in vivo by estrogen and progesterone.
    Craig AM; Denhardt DT
    Gene; 1991 Apr; 100():163-71. PubMed ID: 2055467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of the mouse gene for secreted phosphoprotein 1 (Spp-1) (2ar, osteopontin, bone sialoprotein 1, 44-kDa bone phosphoprotein, tumor-secreted phosphoprotein) to chromosome 5, closely linked to Ric (Rickettsia resistance).
    Fet V; Dickinson ME; Hogan BL
    Genomics; 1989 Aug; 5(2):375-7. PubMed ID: 2571582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation.
    Senger DR; Perruzzi CA; Papadopoulos A
    Anticancer Res; 1989; 9(5):1291-9. PubMed ID: 2686530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.
    Hsieh YH; Juliana MM; Hicks PH; Feng G; Elmets C; Liaw L; Chang PL
    Cancer Res; 2006 Jul; 66(14):7119-27. PubMed ID: 16849558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin.
    Rho O; Bol DK; You J; Beltrán L; Rupp T; DiGiovanni J
    Mol Carcinog; 1996 Oct; 17(2):62-9. PubMed ID: 8890954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of transformation-sensitive secreted phosphoprotein (SPPI/osteopontin) expression by transforming growth factor-beta. Comparisons with expression of SPARC (secreted acidic cysteine-rich protein).
    Wrana JL; Kubota T; Zhang Q; Overall CM; Aubin JE; Butler WT; Sodek J
    Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):523-31. PubMed ID: 1996953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol.
    Kiguchi K; Beltrán L; Rupp T; DiGiovanni J
    Mol Carcinog; 1998 Jun; 22(2):73-83. PubMed ID: 9655251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli.
    Lopez CA; Hoyer JR; Wilson PD; Waterhouse P; Denhardt DT
    Lab Invest; 1993 Sep; 69(3):355-63. PubMed ID: 8377476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. v-ras genes from Harvey and BALB murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis.
    Brown K; Quintanilla M; Ramsden M; Kerr IB; Young S; Balmain A
    Cell; 1986 Aug; 46(3):447-56. PubMed ID: 3015415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model.
    Oates AJ; Barraclough R; Rudland PS
    Oncogene; 1996 Jul; 13(1):97-104. PubMed ID: 8700559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
    Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of antisense osteopontin RNA inhibits tumor promoter-induced neoplastic transformation of mouse JB6 epidermal cells.
    Su L; Mukherjee AB; Mukherjee BB
    Oncogene; 1995 Jun; 10(11):2163-9. PubMed ID: 7784060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 356.